The Essential Role of Tumor Suppressor Gene in Various Human Cancers and Non-neoplastic Disorders

Overview

Journal Biosci Rep

Specialty Cell Biology

Date 2019 Jan 16

PMID 30643005

Citations 9

Authors

Yang Du

Yan Cheng

Guanfang Su

Affiliations

Soon will be listed here.

Abstract

Inhibitor of growth 4 (ING4), a member of the ING family discovered in 2003, has been shown to act as a tumor suppressor and is frequently down-regulated in various human cancers. Numerous published and studies have shown that ING4 is responsible for important cancer hallmarks such as pathologic cell cycle arrest, apoptosis, autophagy, contact inhibition, and hypoxic adaptation, and also affects tumor angiogenesis, invasion, and metastasis. These characteristics are typically associated with regulation through chromatin acetylation by binding histone H3 trimethylated at lysine 4 (H3K4me3) and through transcriptional activity of transcription factor P53 and NF-κB. In addition, emerging evidence has indicated that abnormalities in ING4 expression and function play key roles in non-neoplastic disorders. Here, we provide an overview of ING4-modulated chromosome remodeling and transcriptional function, as well as the functional consequences of different genetic variants. We also present the current understanding concerning the role of ING4 in the development of neoplastic and non-neoplastic diseases. These studies offer inspiration for pursuing novel therapeutics for various cancers.

Citing Articles

Tumor immune microenvironment permissive to metastatic progression of ING4-deficient breast cancer.

Tsutsumi E, Macy A, LoBello J, Hastings K, Kim S PLoS One. 2024; 19(7):e0304194.

PMID: 38968186 PMC: 11226078. DOI: 10.1371/journal.pone.0304194.

Deciphering the dual roles of PHD finger proteins from oncogenic drivers to tumor suppressors.

Fan T, Jiang L, Zhou X, Chi H, Zeng X Front Cell Dev Biol. 2024; 12:1403396.

PMID: 38813086 PMC: 11133592. DOI: 10.3389/fcell.2024.1403396.

Role of PPARG in Chemosensitivity-Regulating Network for Hypopharyngeal Squamous Cell Carcinoma.

Kong F, Han B, Chen J, Shen X, Hou L, Fang J PPAR Res. 2023; 2023:6019318.

PMID: 37791141 PMC: 10545467. DOI: 10.1155/2023/6019318.

Molecular mechanisms of inhibitor of growth (ING) family members in health and malignancy.

Taheri M, Hussen B, Najafi S, Abak A, Ghafouri-Fard S, Samsami M Cancer Cell Int. 2022; 22(1):272.

PMID: 36056353 PMC: 9438315. DOI: 10.1186/s12935-022-02693-w.

Lentiviral vector with a radiation-inducible promoter, carrying the ING4 gene, mediates radiosensitization controlled by radiotherapy in cervical cancer cells.

Ma T, Guo R, Wang X, Shen W, Zhu M, Jin Y Oncol Lett. 2020; 21(1):67.

PMID: 33365078 PMC: 7716713. DOI: 10.3892/ol.2020.12328.

References

Culurgioni S, Munoz I, Moreno A, Palacios A, Villate M, Palmero I . Crystal structure of inhibitor of growth 4 (ING4) dimerization domain reveals functional organization of ING family of chromatin-binding proteins. J Biol Chem. 2012; 287(14):10876-84. PMC: 3322854. DOI: 10.1074/jbc.M111.330001. View

Zhang X, Wang K, Wang Z, Xu L, Wang Q, Chen F . Nuclear localization signal of ING4 plays a key role in its binding to p53. Biochem Biophys Res Commun. 2005; 331(4):1032-8. DOI: 10.1016/j.bbrc.2005.04.023. View

Kouzarides T . Chromatin modifications and their function. Cell. 2007; 128(4):693-705. DOI: 10.1016/j.cell.2007.02.005. View

Huang J, Cui S, Chen Y, Song H, Huang G, Feng B . MicroRNA-650 was a prognostic factor in human lung adenocarcinoma and confers the docetaxel chemoresistance of lung adenocarcinoma cells via regulating Bcl-2/Bax expression. PLoS One. 2013; 8(8):e72615. PMC: 3749147. DOI: 10.1371/journal.pone.0072615. View

Moreno A, Palacios A, Orgaz J, Jimenez B, Blanco F, Palmero I . Functional impact of cancer-associated mutations in the tumor suppressor protein ING4. Carcinogenesis. 2010; 31(11):1932-8. DOI: 10.1093/carcin/bgq171. View

Li J, Martinka M, Li G . Role of ING4 in human melanoma cell migration, invasion and patient survival. Carcinogenesis. 2008; 29(7):1373-9. DOI: 10.1093/carcin/bgn086. View

Tsai K, Tseng H, Lin W . Two wobble-splicing events affect ING4 protein subnuclear localization and degradation. Exp Cell Res. 2008; 314(17):3130-41. DOI: 10.1016/j.yexcr.2008.08.002. View

Ashshi A, El-Shemi A, Dmitriev I, Kashentseva E, Curiel D . Combinatorial strategies based on CRAd-IL24 and CRAd-ING4 virotherapy with anti-angiogenesis treatment for ovarian cancer. J Ovarian Res. 2016; 9(1):38. PMC: 4924320. DOI: 10.1186/s13048-016-0248-5. View

Saha A, Bamidele A, Murakami M, Robertson E . EBNA3C attenuates the function of p53 through interaction with inhibitor of growth family proteins 4 and 5. J Virol. 2010; 85(5):2079-88. PMC: 3067769. DOI: 10.1128/JVI.02279-10. View

10.

Kuninty P, Bojmar L, Tjomsland V, Larsson M, Storm G, Ostman A . MicroRNA-199a and -214 as potential therapeutic targets in pancreatic stellate cells in pancreatic tumor. Oncotarget. 2016; 7(13):16396-408. PMC: 4941323. DOI: 10.18632/oncotarget.7651. View

11.

Chen Y, Fu R, Xu M, Huang Y, Sun G, Xu L . N-methyl-N-nitro-N-nitrosoguanidine-mediated ING4 downregulation contributed to the angiogenesis of transformed human gastric epithelial cells. Life Sci. 2018; 199:179-187. DOI: 10.1016/j.lfs.2018.02.034. View

12.

Shen J, Unoki M, Ythier D, Duperray A, Varticovski L, Kumamoto K . Inhibitor of growth 4 suppresses cell spreading and cell migration by interacting with a novel binding partner, liprin alpha1. Cancer Res. 2007; 67(6):2552-8. PMC: 2569966. DOI: 10.1158/0008-5472.CAN-06-3870. View

13.

Walzak A, Veldhoen N, Feng X, Riabowol K, Helbing C . Expression profiles of mRNA transcript variants encoding the human inhibitor of growth tumor suppressor gene family in normal and neoplastic tissues. Exp Cell Res. 2007; 314(2):273-85. DOI: 10.1016/j.yexcr.2007.07.029. View

14.

Iizuka M, Sarmento O, Sekiya T, Scrable H, Allis C, Smith M . Hbo1 Links p53-dependent stress signaling to DNA replication licensing. Mol Cell Biol. 2007; 28(1):140-53. PMC: 2223294. DOI: 10.1128/MCB.00662-07. View

15.

Li M, Zhu Y, Zhang H, Li L, He P, Xia H . Delivery of inhibitor of growth 4 (ING4) gene significantly inhibits proliferation and invasion and promotes apoptosis of human osteosarcoma cells. Sci Rep. 2014; 4:7380. PMC: 4260466. DOI: 10.1038/srep07380. View

16.

Cai L, Li H, Chen C, Cheng X, Wang Y, Liu J . Role of inhibitor of growth 4 in the suppression of human melanoma cells through the Fas/FasL-mediated apoptosis pathway. Int J Mol Med. 2017; 41(2):1055-1061. DOI: 10.3892/ijmm.2017.3274. View

17.

Chen Y, Huang Y, Hou P, Zhang Z, Zhang Y, Wang W . ING4 suppresses tumor angiogenesis and functions as a prognostic marker in human colorectal cancer. Oncotarget. 2016; 7(48):79017-79031. PMC: 5346695. DOI: 10.18632/oncotarget.12984. View

18.

Cai L, Li X, Zheng S, Wang Y, Wang Y, Li H . Inhibitor of growth 4 is involved in melanomagenesis and induces growth suppression and apoptosis in melanoma cell line M14. Melanoma Res. 2009; 19(1):1-7. DOI: 10.1097/CMR.0b013e32831bc42f. View

19.

Carmeliet P, Jain R . Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases. Nat Rev Drug Discov. 2011; 10(6):417-27. DOI: 10.1038/nrd3455. View

20.

Burset M, Seledtsov I, Solovyev V . SpliceDB: database of canonical and non-canonical mammalian splice sites. Nucleic Acids Res. 2000; 29(1):255-9. PMC: 29840. DOI: 10.1093/nar/29.1.255. View